Correction: The Role of Interleukin−6 in Prematurity Complications
Overview
This correction addresses errors in the reporting of interleukin−6 (IL−6) as a biomarker for complications associated with prematurity. Key updates include corrections to Table 1 and textual errors in the manuscript, specifically regarding the description of IL−6's role in various complications.
Background
Complications from prematurity significantly impact the health of preterm infants, contributing to high mortality rates and long-term health issues. Interleukin−6 (IL−6) is implicated in various neonatal complications.
Data Highlights
Complication
IL−6 AUC
CI
Neonatal Septicemia
0.88
95% CI
Key Findings
IL−6 levels are elevated in several complications associated with prematurity, including BPD, NES, ROP, AKI, NEC, and HIE.
In a cohort study, cord blood IL−6 predicted early-onset neonatal sepsis more effectively than CRP.
IL−6 thresholds for diagnosing sepsis in preterm infants remain undefined.
Corrections were made to the description of IL−6's role in ROP and other sections of the manuscript.
Clinical Implications
Understanding the precise role of IL−6 could inform future research on complications associated with prematurity.
Conclusion
The corrections made in this publication clarify the role of IL−6 in prematurity complications.
